A 52-year-old man with a history of hypertension and diabetes presents with spontaneous hypokalemia (K⁺ 2.9 mEq/L), metabolic alkalosis, and suppressed plasma renin activity despite diuretic therapy. Serum aldosterone is elevated at 22 ng/dL. Which investigation is most appropriate to localize the source of excess aldosterone?

Explanation

## Clinical Presentation Analysis The patient presents with **primary hyperaldosteronism (Conn's syndrome)**: - Hypokalemia and metabolic alkalosis (aldosterone excess) - Suppressed plasma renin activity (autonomous aldosterone production) - Elevated serum aldosterone The diagnostic challenge is **localizing the source**: unilateral adenoma (aldosterone-producing adenoma, APA) vs. bilateral adrenal hyperplasia (idiopathic hyperaldosteronism, IHA). ## Localization Strategy **Key Point:** **Adrenal venous sampling (AVS)** is the gold standard for localizing the source of excess aldosterone production. ### Why AVS? 1. **Functional localization:** AVS measures aldosterone and cortisol from each adrenal vein separately, allowing direct comparison of aldosterone secretion between sides. 2. **Diagnostic criteria:** - **Lateralization ratio:** Aldosterone from affected side / Aldosterone from unaffected side > 4:1 (or > 3:1 with ACTH stimulation) → suggests **unilateral APA** - **No lateralization (ratio < 2:1)** → suggests **bilateral IHA** 3. **Clinical importance:** Distinguishes surgical candidates (APA) from medical management candidates (IHA). 4. **Simultaneous cortisol measurement:** Confirms successful catheterization of adrenal veins (high cortisol indicates correct placement); normalizes for differences in adrenal blood flow. ## Diagnostic Algorithm for Primary Hyperaldosteronism ```mermaid flowchart TD A[Hypokalemia + Hypertension]:::outcome --> B[Screen: ARR > 20]:::decision B -->|Yes| C[Confirm diagnosis:<br/>Saline suppression or<br/>Captopril challenge]:::action C -->|Confirmed| D[Localize source:<br/>Imaging + AVS]:::action D --> E{AVS ratio?}:::decision E -->|> 4:1| F[Unilateral APA]:::outcome E -->|< 2:1| G[Bilateral IHA]:::outcome F --> H[Adrenalectomy]:::action G --> I[Medical management<br/>Spironolactone/Eplerenone]:::action ``` ## Why Other Tests Are Not Localization Tools | Test | Purpose | Limitation for Localization | | --- | --- | --- | | **Imaging (CT/MRI)** | Detect adenoma | Cannot assess *function*; adenomas may be non-secreting; hyperplasia appears bilateral | | **ARR + postural challenge** | Confirms diagnosis | Helps differentiate APA from IHA clinically, but does NOT localize; no direct aldosterone measurement from each gland | | **Captopril challenge** | Confirms autonomous aldosterone | Diagnostic test, not localizing test | **High-Yield:** Imaging (CT/MRI) is done *before* AVS to exclude large masses and guide catheterization, but it cannot localize functional aldosterone production. AVS is the definitive localizing test. **Clinical Pearl:** AVS should be performed with ACTH stimulation (cosyntropin 250 μg IV) to improve selectivity and reduce the impact of adrenal vein compression during catheterization.